Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CTA-positive, angiography-negative lower GI bleeding: an institutional imaging-guided management algorithm.

Emergency radiology·2026
Same author

Outcomes of Hepatocellular Carcinoma involving the Portal Vein Main Trunk and/or the Inferior Vena Cava: Experience From a Multidisciplinary Liver Cancer Clinic.

Cancer medicine·2026
Same author

WE-UNet: A Wavelet-enhanced U-Net framework for radiation dose reduction in chest radiography.

Journal of applied clinical medical physics·2026
Same author

Recent developments and prospects in locoregional therapy of hepatocellular carcinoma.

Abdominal radiology (New York)·2026
Same author

Thyroid Artery Embolization for Benign Thyroid Hyperplasia.

Journal of clinical medicine·2026
Same author

Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience.

Journal of hepatocellular carcinoma·2026

相关实验视频

Updated: May 5, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K

放射性栓塞的新前沿 在放射性栓塞的新前沿.

Arian Mansur1, Peiman Habibollahi2, Adam Fang3

  • 1Harvard Medical School, Boston, MA, USA.

Therapeutic advances in medical oncology
|October 7, 2024
PubMed
概括

放射栓塞使用向辐射珠治疗肝癌,从息护理发展为治愈意图,新辅助疗法和移植桥梁. 这种疗法对于治疗肝细胞癌和肝转移至关重要.

关键词:
剂量测量方法 剂量测量方法眼睛90 眼睛90 眼睛霍尔米亚姆 (Holmium) 是一个体.放射性栓塞是一种放射性栓塞.选择性内部辐射疗法

更多相关视频

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.5K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

394

相关实验视频

Last Updated: May 5, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.5K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

394

科学领域:

  • 干预性放射学 干预性放射学
  • 核医学就是核医学.
  • 在瘤学瘤学.

背景情况:

  • 放射栓塞是一种通过辐射核酸载荷微球传递内部辐射的跨动脉疗法.
  • 它的应用已经扩大到除了息护理之外,包括肝脏疾病的治疗,新辅助和桥梁疗法.

研究的目的:

  • 提供放射性栓塞技术的全面概述.
  • 讨论当前的挑战和该领域的新兴发展.
  • 为了突出剂量测量,放射性核素和瘤向应用的进展.

主要方法:

  • 审查目前的文献和临床实践在放射栓塞.
  • 分析辐射输送和瘤向技术的发展.
  • 探索新的剂量测量方法和放射性核化物剂.

主要成果:

  • 放射栓塞越来越多地用于肝细胞癌和肝转移.
  • 治疗的作用已经显著扩大,提供了多功能治疗选择.
  • 新的发展正在提高精度和扩大放射性栓塞的范围.

结论:

  • 放射栓塞是肝脏恶性瘤的重要治疗选择.
  • 持续的进步有望提高效率和更广泛的适用性.
  • 对新技术和目标的进一步研究将继续塑造其在瘤学中的作用.